Meta-Analyses Involving Cross-Over Trials: Methodological Issues

Stedman MR, Curtin F, Elbourne DR, Kesselheim AS, Brookhart MA - International Journal of Epidemiology

  • Regulation and Clinical Evidence

Summary:

This methodological paper provides a corrected description of the Becker-Balagtas approach for combining results from cross-over trials with binary outcomes alongside parallel-design trials in meta-analyses. The authors present a revised formulation of the marginal odds ratio estimation method and demonstrate its implementation with a worked example comparing brand-name and generic anti-epileptic drugs, providing practical guidance for researchers conducting meta-analyses that include both cross-over and parallel trial designs.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

Politics and the Patient Encounter, in Dire Times

Avorn J - MedPage Today

  • Regulation and Clinical Evidence